US4115409A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Alkanolamine derivatives
Assignee: Imperial Chemical Industries Ltd
•
Filing: 1976-11-26
•
Granted: 1978-09-19
•
Expires: 1996-11-26
Abstract
Abstract Novel 1-aryloxy-3-carbamoylalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess beta -adrenergic blocking activity. Representative of the compounds disclosed is 1-(2-cyanophenoxy)-3- beta -(N-2-furfurylcarbamoyl)ethylamino-2-propanol.
Inventors
- 👤 Michael Stewart Large
- 👤 Leslie Harold Smith
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 23:42
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/36; C07D213/40; A; A61; A61P; A61P9/00; A61P9/06; A61P9/08; A61P9/10; C07D307/00; C07D307/02; C07D307/34; C07D307/38; C07D307/52; C07D307/77; C07D307/78; C07D307/79; C07D309/00; C07D309/02; C07D309/04; C07D319/00; C07D319/10; C07D319/14; C07D319/16; C07D319/18; C07D333/00; C07D333/50; C07D333/52; C07D333/54
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
159 words
An alkanolamine derivative selected from the group consisting of a compound of the formula: R--OCH.sub.2.CHOH.CH.sub.2 NH--A--CO--NH--Y--R.sup.1 wherein A is alkylene of up to 12 carbon atoms; wherein Y is a direct link, or alkylene of up to 6 carbon atoms or alkyleneoxy of from 2 to 6 carbon atoms; wherein R is aryl of the formula: ##STR14## wherein R 2 and R 3 , may be the same or different, each is hydrogen, halogen, hydroxy, amino, nitro, or cyano, alkyl, hydroxyalkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, cycloalkoxy, alkenyloxy, alkynyloxy or alkanoyl each of up to 6 carbon atoms, or aryl, aryloxy or dialkylamino each of up to 12 carbon atoms; or wherein R 2 and R 3 together form trimethylene, tetramethylene, 1-oxotetramethylene, propenylene, but-2-enylene or buta-1,3-dienylene such that together with the adjacent benzene ring they form respectively indanyl, 5,6,7,8-tetrahydronaphthyl, 5-oxo-5,7,7,8-tetrahydronaphthyl, indenyl, 5,8-dihydronaphthyl or naphthyl; and wherein R 1 is furyl or thienyl; and a non-toxic pharmaceutically-acceptable acid-addition salt thereof.
Claim 2
Dependent Claim
159 words
An alkanolamine derivative selected from the group consisting of a compound of the formula: R--OCH.sub.2.CHOH.CH.sub.2 NH--A--CO--NH--Y--R.sup.1 wherein A is alkylene of up to 12 carbon atoms; wherein Y is a direct link, or alkylene of up to 6 carbon atoms or alkyleneoxy of from 2 to 6 carbon atoms; wherein R is aryl of the formula: ##STR14## wherein R 2 and R 3 , may be the same or different, each is hydrogen, halogen, hydroxy, amino, nitro, or cyano, alkyl, hydroxyalkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, cycloalkoxy, alkenyloxy, alkynyloxy or alkanoyl each of up to 6 carbon atoms, or aryl, aryloxy or dialkylamino each of up to 12 carbon atoms; or wherein R 2 and R 3 together form trimethylene, tetramethylene, 1-oxotetramethylene, propenylene, but-2-enylene or buta-1,3-dienylene such that together with the adjacent benzene ring they form respectively indanyl, 5,6,7,8-tetrahydronaphthyl, 5-oxo-5,7,7,8-tetrahydronaphthyl, indenyl, 5,8-dihydronaphthyl or naphthyl; and wherein R 1 is furyl or thienyl; and a non-toxic pharmaceutically-acceptable acid-addition salt thereof.
Claim 3
Dependent Claim
98 words
An alkanolamine derivative as claimed in claim 1 selected from the group consisting of a compound of the formula given in claim 1 wherein A is ethylene, trimethylene, 1-methylethylene or 1,1-dimethylethylene; wherein R 2 is in the 2-position of the phenyl nucleus and is hydrogen, chloro, cyano or alkyl or alkoxy each of up to 3 carbon atoms, and R 3 is hydrogen, or R is unsubstituted naphthyl and wherein Y is a direct link, or alkylene of up to 3 carbon atoms or alkyleneoxy of 2 to 4 carbon atoms; and a non-toxic, pharmaceutically-acceptable acid-addition salt thereof.
Claim 4
Dependent Claim
63 words
An alkanolamine derivative as claimed in claim 2 wherein A is ethylene, R 2 is in the 2-position of the phenyl nucleus and is hydrogen, chloro or cyano, or alkyl or alkoxy each of up to 3 carbon atoms, and R 3 is hydrogen, or R is unsubstituted 1-naphthyl; R 1 is 2-furyl and Y is methylene, or non-toxic, pharmaceutically-acceptable acid-addition salt thereof.
Claim 5
Dependent Claim
35 words
An acid-addition salt as claimed in claim 1 which is a hydrochloride, hydrobromide, phosphate, sulphate, oxalate, lactate, tartrate, acetate, salicylate, citrate, benzoate, β-naphthaoate, adipate or 1,1-methylene-bis-(2-hydroxy-3-naphthoate), or a salt derived from a sulphonated polystyrene resin.
Claim 6
Dependent Claim
14 words
The compound 1-phenoxy-, 1-(2-cyanophenoxy)-, 1-(2-chlorophenoxy)-, or 1-(2-methoxyphenoxy)-3-β-(N-2-furfurylcarbamoyl)ethylamino-2-propanol or a non-toxic, pharmaceutically-acceptable acid-addition salt thereof.
Claim 7
Dependent Claim
14 words
The compound 1-phenoxy-, 1-(2-cyanophenoxy)-, 1-(2-chlorophenoxy)-, or 1-(2-methoxyphenoxy)-3-β-(N-2-furfurylcarbamoyl)ethylamino-2-propanol or a non-toxic, pharmaceutically-acceptable acid-addition salt thereof.
Claim 8
Dependent Claim
20 words
An alkanolamine derivative as claimed in claim 1, said derivative being 1-2(2-tolyloxy)-3-β-(N-2-furfurylcarbamoyl) ethyl amino-2-propanol or non-toxic, phamaceutically-acceptable acid-addition salt thereof.
References Cited (Backward Citations)
US2776991A
Cited
US3793365A
Cited
US3944611A
Cited
US4034112A
Cited
US3933911A
Cited
US3957870A
Cited
US4034106A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-09-18 | 1982-03-20 | 1982-09-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-09-18 | 1986-03-20 | 1986-09-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-09-18 | 1990-03-20 | 1990-09-19 | $7700.00 | Window Closed / Lapsed |